Novo Nordisk (NVO)
(Real Time Quote from BATS)
$126.71 USD
+1.27 (1.01%)
Updated Sep 25, 2024 12:17 PM ET
3-Hold of 5 3
C Value B Growth B Momentum B VGM
Novo Nordisk A/S - Hold
Zacks' proprietary data indicates that Novo Nordisk A/S is currently rated as a Zacks Rank 3 and we are expecting an inline return from the NVO shares relative to the market in the next few months. In addition, Novo Nordisk A/S has a VGM Score of B (this is a weighted average of the individual Style Scores which allow you to focus on the stocks that best fit your personal trading style). Valuation metrics show that Novo Nordisk A/S may be fairly valued. Its Value Score of C indicates it would be a neutral pick for value investors. The financial health and growth prospects of NVO, demonstrate its potential to perform inline with the market. It currently has a Growth Score of B. Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of B.
Style Scorecard
Value Scorecard
Growth Scorecard
Momentum Scorecard
Value Score | NVO: C | Industry [X] | LLY: F | NVS: B | AZN: B |
---|---|---|---|---|---|
Zacks Rank | 3 | 1 | 3 | 2 | |
VGM Score | B | F | C | D | |
Cash/Price | 0.02 | 0.04 | 0.00 | 0.04 | 0.03 |
EV/EBITDA | 33.64 | 20.91 | 111.23 | 13.57 | 18.58 |
PEG Ratio | 1.37 | 1.68 | 2.80 | 1.74 | 1.45 |
Price/Book (P/B) | 34.67 | 5.85 | 64.43 | 5.68 | 6.02 |
Price/Cash Flow (P/CF) | 41.66 | 12.07 | 121.21 | 10.48 | 14.24 |
P/E (F1) | 40.39 | 15.89 | 56.06 | 15.53 | 18.97 |
Price/Sales (P/S) | 15.04 | 4.76 | 22.57 | 4.97 | 4.85 |
Earnings Yield | 2.48% | 6.30% | 1.78% | 6.44% | 5.27% |
Debt/Equity | 0.46 | 0.68 | 1.74 | 0.47 | 0.69 |
Cash Flow ($/share) | 3.01 | 4.62 | 7.63 | 11.11 | 5.40 |
Growth Score | NVO: B | Industry [X] | LLY: F | NVS: D | AZN: D |
---|---|---|---|---|---|
Zacks Rank | 3 | 1 | 3 | 2 | |
VGM Score | B | F | C | D | |
Hist. EPS Growth | 19.87% | 5.83% | 3.14% | 5.83% | 19.04% |
Proj. EPS Growth | 15.04% | 6.38% | 160.93% | 8.68% | 11.62% |
Curr. Cash Flow Growth | 51.72% | 1.35% | -16.87% | 11.80% | 5.97% |
Hist. Cash Flow Growth | 14.98% | 3.34% | -0.31% | 5.77% | 15.51% |
Current Ratio | 0.94 | 1.04 | 1.11 | 0.93 | 0.89 |
Debt/Capital | 31.44% | 40.47% | 63.51% | 31.94% | 40.74% |
Net Margin | 34.86% | 18.86% | 18.86% | 33.76% | 13.11% |
Return on Equity | 87.43% | 34.56% | 67.52% | 34.56% | 29.34% |
Sales/Assets | 0.80 | 0.49 | 0.60 | 0.47 | 0.49 |
Proj. Sales Growth (F1/F0) | 26.40% | 5.91% | 35.82% | -0.56% | 14.55% |
Momentum Score | NVO: B | Industry [X] | LLY: F | NVS: C | AZN: F |
---|---|---|---|---|---|
Zacks Rank | 3 | 1 | 3 | 2 | |
VGM Score | B | F | C | D | |
Daily Price Chg | 1.41% | 0.19% | 0.64% | 0.04% | -0.35% |
1 Week Price Chg | -4.97% | 0.19% | 2.01% | 0.62% | -2.11% |
4 Week Price Chg | -7.21% | -1.28% | -3.15% | -2.85% | -11.86% |
12 Week Price Chg | -12.27% | 10.42% | 1.95% | 9.38% | -0.16% |
52 Week Price Chg | 36.66% | 13.73% | 68.07% | 14.79% | 12.68% |
20 Day Average Volume | 3,148,426 | 2,871,950 | 2,595,474 | 1,033,907 | 4,481,599 |
(F1) EPS Est. Wkly Chg | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
(F1) EPS Est. Mthly Chg | 0.00% | 0.00% | -0.19% | 0.21% | 0.00% |
(F1) EPS Est. Qtrly Chg | -8.83% | 0.84% | 19.83% | 2.92% | 0.58% |
(Q1) EPS Est. Mthly Chg | 0.00% | 0.03% | 4.03% | 0.31% | 0.00% |
Zacks News for NVO
VTYX Stock Rises on Strategic Equity Investment Deal With SNY
NVO: What are Zacks experts saying now?
Zacks Private Portfolio Services